Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
As Associate Director / Director of HCP Marketing at Capricor, you will lead the development and execution of the healthcare professional marketing strategy for deramiocel, Capricor’s first commercial product, a cell therapy for Duchenne muscular dystrophy (DMD). In this role, you will translate clinical evidence, market insights, and competitive intelligence into differentiated messaging and a multi-channel education and promotional campaign that drives awareness, adoption, and appropriate use among neuromuscular specialists and the broader DMD care team. You will own brand planning and execution for the HCP audience, manage agency and vendor partners, and serve as a key cross-functional partner across the commercial organization. The ideal candidate brings deep biopharmaceutical brand marketing expertise, a builder mindset suited to a first-launch environment, and a genuine commitment to serving the rare disease community.
As Associate Director / Director of HCP Marketing at Capricor, you will lead the development and execution of the healthcare professional marketing strategy for deramiocel, Capricor’s first commercial product, a cell therapy for Duchenne muscular dystrophy (DMD). In this role, you will translate clinical evidence, market insights, and competitive intelligence into differentiated messaging and a multi-channel education and promotional campaign that drives awareness, adoption, and appropriate use among neuromuscular specialists and the broader DMD care team. You will own brand planning and execution for the HCP audience, manage agency and vendor partners, and serve as a key cross-functional partner across the commercial organization. The ideal candidate brings deep biopharmaceutical brand marketing expertise, a builder mindset suited to a first-launch environment, and a genuine commitment to serving the rare disease community.
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.
